Published in Eur J Pharm Biopharm on November 18, 2010
Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano (2011) 1.47
Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proc Natl Acad Sci U S A (2013) 1.37
In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics. J Control Release (2012) 1.21
Scavenger receptor mediated endocytosis of silver nanoparticles into J774A.1 macrophages is heterogeneous. ACS Nano (2012) 1.09
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev (2015) 1.08
Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine (Lond) (2014) 1.07
Gold nanoparticle delivery of modified CpG stimulates macrophages and inhibits tumor growth for enhanced immunotherapy. PLoS One (2013) 1.06
Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice. Virology (2013) 1.05
Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virus. Nano Lett (2014) 1.04
Nanoparticle characterization: state of the art, challenges, and emerging technologies. Mol Pharm (2013) 1.04
Plasmid-templated shape control of condensed DNA-block copolymer nanoparticles. Adv Mater (2012) 1.02
Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma. Biomaterials (2013) 1.00
Biologically optimized nanosized molecules and particles: more than just size. Bioconjug Chem (2011) 1.00
Roadmap to Clinical Use of Gold Nanoparticles for Radiation Sensitization. Int J Radiat Oncol Biol Phys (2015) 0.96
Engineered nanomaterial uptake and tissue distribution: from cell to organism. Int J Nanomedicine (2013) 0.95
Three-dimensional optoacoustic imaging as a new noninvasive technique to study long-term biodistribution of optical contrast agents in small animal models. J Biomed Opt (2012) 0.95
Design rules for nanomedical engineering: from physical virology to the applications of virus-based materials in medicine. J Biol Phys (2013) 0.94
Retracted Fabrication of highly uniform nanoparticles from recombinant silk-elastin-like protein polymers for therapeutic agent delivery. ACS Nano (2011) 0.93
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem Soc Rev (2015) 0.92
Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo. Nanomedicine (2015) 0.92
Targeted nanotechnology for cancer imaging. Adv Drug Deliv Rev (2014) 0.91
Functionalized Gold Nanoparticles and Their Biomedical Applications. Nanomaterials (Basel) (2011) 0.90
Stealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X. Acta Biomater (2015) 0.90
Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines. Theranostics (2015) 0.89
A Review of Molecular Mechanisms Involved in Toxicity of Nanoparticles. Adv Pharm Bull (2015) 0.89
Interface of physics and biology: engineering virus-based nanoparticles for biophotonics. Bioconjug Chem (2015) 0.88
Development and optimization of near-IR contrast agents for immune cell tracking. Biomed Opt Express (2013) 0.88
Effect of surface charge on the colloidal stability and in vitro uptake of carboxymethyl dextran-coated iron oxide nanoparticles. J Nanopart Res (2013) 0.86
Efficient hepatic delivery of drugs: novel strategies and their significance. Biomed Res Int (2013) 0.85
Effect of aspect ratio and deformability on nanoparticle extravasation through nanopores. Langmuir (2012) 0.84
Conversion of rod-shaped gold nanoparticles to spherical forms and their effect on biodistribution in tumor-bearing mice. Nanoscale Res Lett (2012) 0.84
A review of nanotechnological approaches for the prophylaxis of HIV/AIDS. Biomaterials (2013) 0.83
Synthetic Strategies for Engineering Intravenous Hemostats. Bioconjug Chem (2015) 0.82
In vivo imaging of nanoparticle delivery and tumor microvasculature with multimodal optical coherence tomography. Biomed Opt Express (2014) 0.82
Dual-modality fiber-based OCT-TPL imaging system for simultaneous microstructural and molecular analysis of atherosclerotic plaques. Biomed Opt Express (2015) 0.81
Effects of the physicochemical properties of gold nanostructures on cellular internalization. Regen Biomater (2015) 0.81
Two-photon luminescence properties of gold nanorods. Biomed Opt Express (2013) 0.81
Tissue distribution and efficacy of gold nanorods coupled with laser induced photoplasmonic therapy in ehrlich carcinoma solid tumor model. PLoS One (2013) 0.81
Emergence and Utility of Nonspherical Particles in Biomedicine. Ind Eng Chem Res (2015) 0.81
Tobacco mosaic virus-based protein nanoparticles and nanorods for chemotherapy delivery targeting breast cancer. J Control Release (2016) 0.81
Detection and imaging of aggressive cancer cells using an epidermal growth factor receptor (EGFR)-targeted filamentous plant virus-based nanoparticle. Bioconjug Chem (2015) 0.80
A Dual Gold Nanoparticle System for Mesenchymal Stem Cell Tracking. J Mater Chem B Mater Biol Med (2014) 0.80
Photothermal optical lock-in optical coherence tomography for in vivo imaging. Biomed Opt Express (2015) 0.79
Effects of naked gold nanoparticles on proinflammatory cytokines mRNA expression in rat liver and kidney. Biomed Res Int (2013) 0.78
Ion-ion correlation, solvent excluded volume and pH effects on physicochemical properties of spherical oxide nanoparticles. J Colloid Interface Sci (2015) 0.78
Low-dose gold nanoparticles exert subtle endocrine-modulating effects on the ovarian steroidogenic pathway ex vivo independent of oxidative stress. Nanotoxicology (2014) 0.78
In vitro and in vivo investigations of upconversion and NIR emitting Gd₂O₃:Er³⁺,Yb³⁺ nanostructures for biomedical applications. J Mater Sci Mater Med (2012) 0.78
The aspect ratio of nanoparticle assemblies and the spatial arrangement of ligands can be optimized to enhance the targeting of cancer cells. Adv Healthc Mater (2014) 0.78
Size Dependent Kinetics of Gold Nanorods in EPR Mediated Tumor Delivery. Theranostics (2016) 0.76
To Target or Not to Target: Active vs. Passive Tumor Homing of Filamentous Nanoparticles Based on Potato virus X. Cell Mol Bioeng (2015) 0.76
Multifunctional nanorods serving as nanobridges to modulate T cell-mediated immunity. ACS Nano (2013) 0.76
Active targeting theranostic iron oxide nanoparticles for MRI and magnetic resonance-guided focused ultrasound ablation of lung cancer. Biomaterials (2017) 0.75
Alkaline and ultrasonic dissolution of biological materials for trace silicon determination. J Vac Sci Technol B Nanotechnol Microelectron (2015) 0.75
Fluorescent Tobacco mosaic virus-Derived Bio-Nanoparticles for Intravital Two-Photon Imaging. Front Plant Sci (2016) 0.75
Detection of gold nanorods uptake by macrophages using scattering analyses combined with diffusion reflection measurements as a potential tool for in vivo atherosclerosis tracking. Int J Nanomedicine (2015) 0.75
Influence of surfactant and lipid type on the physicochemical properties and biocompatibility of solid lipid nanoparticles. Int J Environ Res Public Health (2014) 0.75
Systematic coarse-grained modeling of complexation between small interfering RNA and polycations. J Chem Phys (2015) 0.75
The Effect of shape on Cellular Uptake of Gold Nanoparticles in the forms of Stars, Rods, and Triangles. Sci Rep (2017) 0.75
Vascular targeting of nanoparticles for molecular imaging of diseased endothelium. Adv Drug Deliv Rev (2016) 0.75
Novel Nanoprinting for Oral Delivery of Poorly Soluble Drugs. Methodist Debakey Cardiovasc J (2016) 0.75
A comparative study of the adhesion of biosynthesized gold and conjugated gold/prodigiosin nanoparticles to triple negative breast cancer cells. J Mater Sci Mater Med (2017) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release (2000) 14.89
Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer (2005) 13.49
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A (2003) 12.17
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett (2006) 10.12
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm (2005) 7.53
Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol (2007) 6.85
Role of target geometry in phagocytosis. Proc Natl Acad Sci U S A (2006) 6.62
PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release (2006) 3.74
Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond) (2007) 3.68
Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv (2004) 3.65
The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem (1995) 2.58
Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells. Proc Natl Acad Sci U S A (2003) 2.37
Biodistribution of 1.4- and 18-nm gold particles in rats. Small (2008) 2.32
Multifunctional nanorods for gene delivery. Nat Mater (2003) 2.09
Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem Int Ed Engl (2005) 2.02
The macrophage. Bioessays (1995) 2.01
Probing BSA binding to citrate-coated gold nanoparticles and surfaces. Langmuir (2005) 1.97
Shape induced inhibition of phagocytosis of polymer particles. Pharm Res (2008) 1.91
The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials (2009) 1.82
Assessment of the In Vivo Toxicity of Gold Nanoparticles. Nanoscale Res Lett (2009) 1.81
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm (2008) 1.78
Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res (2007) 1.77
Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials (2010) 1.77
Treatment goals in ovarian cancer. Int J Gynecol Cancer (2005) 1.75
Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res (1991) 1.70
Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating. Int J Pharm (2002) 1.58
Increased sensitivity of surface plasmon resonance of gold nanoshells compared to that of gold solid colloids in response to environmental changes. Anal Chem (2002) 1.54
Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem Biophys Res Commun (1991) 1.50
Biological approaches to the controlled delivery of drugs: a critical review. Pharmacol Rev (1984) 1.47
Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres. J Appl Toxicol (2010) 1.38
Nanodisks: hydrophobic drug delivery vehicles. Expert Opin Drug Deliv (2008) 1.31
The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. J Control Release (2009) 1.28
Cellular uptake and cytotoxicity of silica nanotubes. Nano Lett (2008) 1.27
Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. Crit Rev Ther Drug Carrier Syst (1994) 1.21
Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages. Pharm Res (2003) 1.03
The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (Poloxamer 338). FEBS Lett (1984) 1.00
Immunolocalizations of VEGF, its receptors flt-1, KDR and TGF-beta's in epithelial ovarian tumors. Histol Histopathol (2006) 0.97
Formaldehyde treated albumin contains monomeric and polymeric forms that are differently cleared by endothelial and Kupffer cells of the liver: evidence for scavenger receptor heterogeneity. Biochem Biophys Res Commun (1991) 0.85
Biosensing with conically shaped nanopores and nanotubes. Phys Chem Chem Phys (2006) 0.80
General, high-affinity approach for the synthesis of fluorophore appended protein nanoparticle assemblies. Chem Commun (Camb) (2005) 0.77
Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med (1976) 7.02
Binding of large organic anions and neutral molecules by native bovine serum albumin. Biochemistry (1966) 5.01
A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol (2001) 3.74
Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem (1997) 3.66
Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci U S A (1991) 2.86
Rehydration versus Growth-induced Water Uptake in Plant Tissues. Plant Physiol (1973) 2.55
Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. J Exp Med (1998) 2.40
AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL. Br J Cancer (2006) 2.33
Pollen tube guidance by the female gametophyte. Development (1997) 2.22
Imaging cells with the atomic force microscope. J Struct Biol (1991) 2.20
NHLBI plans for the promise of cell-based therapies. Cytotherapy (2005) 2.04
The prenatal detection of significant alcohol exposure with maternal blood markers. J Pediatr (1998) 1.96
p53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet (1991) 1.95
Effects of iron chelators and iron overload on Salmonella infection. Nature (1977) 1.89
Maternal effects of the short integument mutation on embryo development in Arabidopsis. Dev Biol (1996) 1.89
Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity (1999) 1.88
Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Hum Mol Genet (2000) 1.85
Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development--Diabetes in Early Pregnancy Study. Am J Obstet Gynecol (1991) 1.75
Genes that are uniquely stress regulated in salt overly sensitive (sos) mutants. Plant Physiol (2001) 1.69
sin 1, a mutation affecting female fertility in Arabidopsis, interacts with mod 1, its recessive modifier. Genetics (1994) 1.66
Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J Clin Invest (1996) 1.66
A relativistic type Ibc supernova without a detected gamma-ray burst. Nature (2010) 1.64
Alcohol metabolism in Asian-American men with genetic polymorphisms of aldehyde dehydrogenase. Ann Intern Med (1997) 1.63
Lipid and Surface Wax Synthesis in Water-stressed Cotton Leaves. Plant Physiol (1978) 1.63
Reversible hematologic sequelae of diabetes mellitus. Ann Intern Med (1977) 1.62
Iron metabolism, sickle cell disease, and response to cyanate. Blood (1975) 1.60
Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett (1997) 1.58
Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J Immunol (1998) 1.58
Tests of glycemia in diabetes. Diabetes Care (1995) 1.51
Monozygotic twinning associated with assisted reproductive technologies: a review. Reproduction (2008) 1.50
A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N Engl J Med (1984) 1.49
A comparative evaluation of glycosylated haemoglobin assays: feasibility of references and standards. Diabetologia (1984) 1.47
Acetaldehyde adducts with hemoglobin. J Clin Invest (1981) 1.46
Sperm DNA fragmentation is increased in couples with unexplained recurrent pregnancy loss. Arch Androl (2003) 1.41
A discriminant function for preeclampsia: case-control study of minor hemoglobins, red cell enzymes, and clinical laboratory values. Am J Perinatol (1997) 1.40
Adaptors, linkers, and methylation. Methods Enzymol (1987) 1.39
Temperature measurement after severe head injury. Anaesthesia (2004) 1.38
Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax (2000) 1.37
What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. Clin Chem (1998) 1.36
Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer (2008) 1.35
Hemoglobin AIc as an indicator of the degree of glucose intolerance in diabetes. Diabetes (1976) 1.35
Localization of the pannexin1 protein at postsynaptic sites in the cerebral cortex and hippocampus. Neuroscience (2007) 1.33
Expression and function of interleukin-6 in epithelial cells. J Cell Biochem (1991) 1.32
Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in nude mice. Eur J Cancer (2001) 1.30
STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia. Mucosal Immunol (2012) 1.29
Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery. Adv Drug Deliv Rev (2011) 1.29
The in vivo mutagenic frequency and specificity of O6-methylguanine in phi X174 replicative form DNA. Proc Natl Acad Sci U S A (1986) 1.27
TLR4/MyD88-induced CD11b+Gr-1 int F4/80+ non-migratory myeloid cells suppress Th2 effector function in the lung. Mucosal Immunol (2010) 1.27
Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression. J Immunol (2000) 1.25
Randomized trial of computer-assisted insulin delivery in patients with type I diabetes beginning pump therapy. Am J Med (1986) 1.24
Temperature effects on radial propagation of water potential in cotton stem bark. Plant Physiol (1973) 1.22
Kinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferative neoplasms. Leukemia (2011) 1.22
Feasibility of improved blood glucose control in patients with insulin-dependent diabetes mellitus. Diabetes Care (1980) 1.21
The CCN family proteins in carcinogenesis. Exp Oncol (2010) 1.21
Drug resistance in mutant FLT3-positive AML. Oncogene (2010) 1.20
Cysteinyl leukotrienes and their receptors: molecular and functional characteristics. Pharmacology (2010) 1.20
Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation. Biochem Biophys Res Commun (1989) 1.19
Epidemiological aspects of mycetoma from a retrospective study of 264 cases in West Bengal. Trop Med Int Health (2002) 1.18
Unusual presentation of acute pancreatitis: an irreducible inguinoscrotal swelling mimicking a strangulated hernia. Abdom Imaging (2007) 1.17
The human "interferon-beta 2/hepatocyte stimulating factor/interleukin-6" gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics (1988) 1.17
Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements. J Biol Chem (1995) 1.16
Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J Allergy Clin Immunol (1999) 1.16
Cloning and polypeptide analysis of the leading region in F plasmid DNA transfer. Plasmid (1983) 1.16
Water soluble polymers in tumor targeted delivery. J Control Release (2001) 1.16
Activated Akt protects the lung from oxidant-induced injury and delays death of mice. J Exp Med (2001) 1.15
Antigenic and molecular heterogeneity of the transferrin-binding protein of Neisseria meningitidis. FEMS Microbiol Lett (1990) 1.14
The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study. Hum Reprod (2013) 1.14
Adenoviral gene delivery to solid tumors by recombinant silk-elastinlike protein polymers. Pharm Res (2007) 1.13
Production of IL-6 by keratinocytes. Implications for epidermal inflammation and immunity. Ann N Y Acad Sci (1989) 1.12
Solvophobic interactions and micelle formation in structure forming nonaqueous solvents. Nature (1971) 1.12
Enhancement of somatic intrachromosomal homologous recombination in Arabidopsis by the HO endonuclease. Plant Cell (1996) 1.11
Effect of obesity on breast cancer development. Vet Pathol (2010) 1.10
Comparison of methods for blood glucose monitoring. Diabetes Care (1982) 1.10
Recombinant polymer-protein fusion: a promising approach towards efficient and targeted gene delivery. J Gene Med (2006) 1.09
Randomized trial of diet versus diet plus cardiovascular conditioning on glucose levels in gestational diabetes. Am J Obstet Gynecol (1989) 1.08
A circuit analog model for studying quantitative water relations of plant tissues. Plant Physiol (1979) 1.08
Inducible lung-specific expression of RANTES: preferential recruitment of neutrophils. Am J Physiol Lung Cell Mol Physiol (2000) 1.07
Rapid detection and sequencing of alleles in the 3' flanking region of the interleukin-6 gene. Nucleic Acids Res (1989) 1.07
Localization of affinity-labeled residues in the primary structure of anti-dinitrophenyl antibody raised in strain 13 guinea pigs. Biochemistry (1972) 1.07
Validation of a vision-based, three-dimensional facial imaging system. Cleft Palate Craniofac J (2003) 1.07
Leiomyomatosis peritonealis disseminata treated with a gonadotropin-releasing hormone agonist. A case report. Am J Obstet Gynecol (1992) 1.07
Minor hemoglobins, diabetic "control", and diseases of postsynthetic protein modification. Ann Intern Med (1977) 1.06
Sonographic diagnosis of peritoneal inclusion cysts. J Ultrasound Med (1995) 1.06
Advances in the treatment of pediatric brain tumors. Expert Rev Neurother (2004) 1.06
Low molecular weight iron-binding factor from mammalian tissue that potentiates bacterial growth. J Exp Med (1980) 1.06
Relation between chubby cheeks and visceral fat. N Engl J Med (1998) 1.06
SH3 binding domains in the dopamine D4 receptor. Biochemistry (1998) 1.06
Hematologic alterations in diabetes mellitus. Am J Med (1981) 1.06
Cloning and analysis of pif, replication and leading regions of the F plasmid. Mol Gen Genet (1984) 1.06
Smac mimetics: implications for enhancement of targeted therapies in leukemia. Leukemia (2010) 1.05
Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair. Lancet (2000) 1.05
Evolving concepts on adjusting human resting energy expenditure measurements for body size. Obes Rev (2012) 1.04
Dietary factors and cancer chemoprevention: an overview of obesity-related malignancies. J Postgrad Med (2009) 1.04
Profile of behavioural risk factors of non-communicable diseases in an urban setting in New Delhi. Indian J Public Health (2009) 1.04
Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers. Int J Pharm (2003) 1.04
Jet-injected insulin is associated with decreased antibody production and postprandial glucose variability when compared with needle-injected insulin in gestational diabetic women. Diabetes Care (1993) 1.04
Effects of ionic protein denaturants on micelle formation by nonionic detergents. J Am Chem Soc (1971) 1.03
A collaborative, double-blind randomized study of cetiedil citrate in sickle cell crisis. Blood (1986) 1.02
Selective up-regulation of cytokine-induced RANTES gene expression in lung epithelial cells by overexpression of IkappaBR. J Biol Chem (1997) 1.01
Extravasation of poly(amidoamine) (PAMAM) dendrimers across microvascular network endothelium. Pharm Res (2001) 1.01